GlassScriptPhysician profile
Sara Ann Oberlander
NPI 1326667155
$1,701.42
in general payments reported to CMS, 2019-2025
17 companies · $599 in 2025
The $599 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $209 · 2022: $125 · 2023: $326 · 2024: $443 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264 · Travel and Lodging: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.62 |
| Travel and Lodging | $104.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $251.86 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $250.99 | 2023-2025 | Relistor |
| Astrazeneca Pharmaceuticals LP | $220.59 | 2021-2023 | Fasenra |
| E.R. Squibb & Sons, L.L.C. | $134.90 | 2023 | Camzyos |
| Avanir Pharmaceuticals, INC. | $124.88 | 2022 | |
| Sanofi-Aventis U.S. LLC | $113.34 | 2021 | |
| Edwards Lifesciences Corporation | $108.01 | 2025 | Sapien 3 Ultra Resilia |
| Vertex Pharmaceuticals Incorporated | $105.39 | 2024-2025 | |
| Averitas Pharma INC. | $90.46 | 2024 | Qutenza |
| Collegium Pharmaceutical, INC. | $62.67 | 2023-2025 | Xtampza, Belbuca |
| Scilex Pharmaceuticals INC. | $52.94 | 2023-2025 | Ztlido |
| Nevro Corp. | $42.22 | 2024 | Senza |
| Ani Pharmaceuticals, INC. | $36.93 | 2025 | Purified Cortrophin Gel |
| Fidia Pharma USA INC. | $32.50 | 2025 | Hymovis |
| Protega Pharmaceutials INC | $30.18 | 2025 | Roxybond |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $21.91 | 2025 | Prialt |
| Convatec INC. | $21.65 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Oberlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.